Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.
Rafael Madero-MarroquinEmily DworkinHoward WeinerCaner SayginMariam T NawasMichael W DrazerAdam S DuVallSatyajit KosuriMichael J ThirmanOlatoyosi OdenikeWendy StockRichard A LarsonAnand Ashwin PatelPublished in: Leukemia & lymphoma (2024)